These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7379054)

  • 1. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 4. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
    Wagstaff J; Anderson HA; Shiu W; Thatcher N
    Cancer Treat Rep; 1983 Sep; 67(9):839-40. PubMed ID: 6883362
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of vindesine in advanced gastric cancer.
    Kenny JB; Scarffe JH; Maley WV
    Cancer Treat Rep; 1983 Jan; 67(1):89-90. PubMed ID: 6311414
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of vindesine in adenocarcinoma of the lung.
    Sledge GW; Clark GM; Von Hoff DD
    Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
    Retsas S; Thomas C; Hobbs JR
    Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma.
    MacKie RM; Gaukroger JM; Wilson L; Gold J
    Cancer Treat Rep; 1984 Sep; 68(9):1185-8. PubMed ID: 6478453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 20. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
    Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
    J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.